» Articles » PMID: 20661421

Association of Rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: the ARIC Study

Overview
Journal PLoS One
Date 2010 Jul 28
PMID 20661421
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The minor T-allele of rs780094 in the glucokinase regulator gene (GCKR) associates with a number of metabolic traits including higher triglyceride levels and improved glycemic regulation in study populations of mostly European ancestry. Using data from the Atherosclerosis Risk in Communities (ARIC) Study, we sought to replicate these findings, examine them in a large population-based sample of African American study participants, and to investigate independent associations with other metabolic traits in order to determine if variation in GKCR contributes to their observed clustering. In addition, we examined the association of rs780094 with incident diabetes, coronary heart disease (CHD), and stroke over up mean follow-up times of 8, 15, and 15 years, respectively.

Research Design And Methods: Race-stratified analyses were conducted among 10,929 white and 3,960 black participants aged 45-64 at baseline assuming an additive genetic model and using linear and logistic regression and Cox proportional hazards models.

Results: Previous findings replicated among white participants in multivariable adjusted models: the T-allele of rs780094 was associated with lower fasting glucose (p = 10(-7)) and insulin levels (p = 10(-6)), lower insulin resistance (HOMA-IR, p = 10(-9)), less prevalent diabetes (p = 10(-6)), and higher CRP (p = 10(-8)), 2-h postprandial glucose (OGTT, p = 10(-6)), and triglyceride levels (p = 10(-31)). Moreover, the T-allele was independently associated with higher HDL cholesterol levels (p = 0.022), metabolic syndrome prevalence (p = 0.043), and lower beta-cell function measured as HOMA-B (p = 0.011). Among black participants, the T-allele was associated only with higher triglyceride levels (p = 0.004) and lower insulin levels (p = 0.002) and HOMA-IR (p = 0.013). Prospectively, the T-allele was associated with reduced incidence of diabetes (p = 10(-4)) among white participants, but not with incidence of CHD or stroke.

Conclusions: Our findings indicate rs780094 has independent associations with multiple metabolic traits as well as incident diabetes, but not incident CHD or stroke. The magnitude of association between the SNP and most traits was of lower magnitude among African American compared to white participants.

Citing Articles

Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.

Hermanson J, Tolba S, Chrisler E, Leone V J Nutr Biochem. 2024; 133:109704.

PMID: 39029595 PMC: 11480923. DOI: 10.1016/j.jnutbio.2024.109704.


Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea.

Kwon Y, Choi J, Hong K, Lee J J Transl Med. 2024; 22(1):591.

PMID: 38918799 PMC: 11197258. DOI: 10.1186/s12967-024-05408-z.


Glucokinase regulatory protein rs780094 polymorphism is associated with type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and nephropathy.

Madhoun A World J Diabetes. 2024; 15(5):814-817.

PMID: 38766433 PMC: 11099372. DOI: 10.4239/wjd.v15.i5.814.


Relationship between gene rs780094 polymorphism and type 2 diabetes with albuminuria.

Liu Y, Wan Q World J Diabetes. 2024; 14(12):1803-1812.

PMID: 38222779 PMC: 10784796. DOI: 10.4239/wjd.v14.i12.1803.


Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD.

Zhang Z, Ji G, Li M Front Endocrinol (Lausanne). 2023; 14:1247611.

PMID: 37711901 PMC: 10497960. DOI: 10.3389/fendo.2023.1247611.


References
1.
Kozian D, Barthel A, Cousin E, Brunnhofer R, Anderka O, Marz W . Glucokinase-activating GCKR polymorphisms increase plasma levels of triglycerides and free fatty acids, but do not elevate cardiovascular risk in the Ludwigshafen Risk and Cardiovascular Health Study. Horm Metab Res. 2010; 42(7):502-6. DOI: 10.1055/s-0030-1249637. View

2.
Grimsby J, Coffey J, Dvorozniak M, Magram J, Li G, Matschinsky F . Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem. 2000; 275(11):7826-31. DOI: 10.1074/jbc.275.11.7826. View

3.
Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M . Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia. 2009; 53(2):299-308. DOI: 10.1007/s00125-009-1595-1. View

4.
Reynolds K, He J . Epidemiology of the metabolic syndrome. Am J Med Sci. 2005; 330(6):273-9. DOI: 10.1097/00000441-200512000-00004. View

5.
Qi Q, Wu Y, Li H, Loos R, Hu F, Sun L . Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia. 2009; 52(5):834-43. DOI: 10.1007/s00125-009-1290-2. View